Targeting retrovirus entry

Gene Therapy

Volumn 3, Issue 11, 1996, Pages 946-956

  Cosset, F L ^a   Russell, S J ^b  

^a CENTRE DE GÉNÉTIQUE MOLÉCULAIRE ET CELLULAIRE   (France)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Gene delivery; Gene therapy; Retroviral display; Retroviral vectors; Targeting

Indexed keywords

VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

EXPRESSION VECTOR; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVIEW; VIRUS CELL INTERACTION;

UNIDENTIFIED RETROVIRUS;

EID: 0029857689     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Weiss RA. Cellular receptors and viral glycoproteins involved in retroviral entry. In: Levy J (ed). The Retroviridae. (Vol 2) Plenum Press: New York, 1993, pp 1-108
2. Yu H, Soong K, Anderson WF. Binding kinetics of ecotropic (Moloney) murine leukemia retrovirus with NIH 3T3 cells. J Virol 1995; 69: 6557-6562.
3. Battini JL et al. Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein. J Virol 1996; 70: 4387-4393.
4. Heard J-M, Danos O. An amino-terminal fragment of the friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor. J Virol 1991; 65: 4026-4032
5. Battini JL, Heard JM, Danos O. Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses. J Virol 1992; 66: 1468-1475.
6. Morgan RA et al. Analysis of the functional and host-range determining regions of the murine ecotropic and amphotropic retrovirus envelope proteins. J Virol 1993; 67: 4712-4721.
7. Ott D, Rein A. Basis for receptor specificity of non-ecotropic murine leukemia virus surface glycoprotein gp70. J Virol 1992; 66: 4632-1638.
8. White JM. Membrane fusion. Science 1992; 258: 917-924.
9. McClure MO, Sommerfelt MA, Marsh M, Weiss RA. The pH independence of mammalian retrovirus infection. J Gen Virol 1990, 71: 767-773.
10. Gallaher WR et al. A general model for the surface glycoproteins of HIV and other retroviruses. AIDS Res Hum Retrovir 1995; 11: 191-202.
11. Fass D, Kim PS. Dissection of a retrovirus envelope protein reveals structural similarity to influenza hemagglutinin. Curr Biol 1995; 5: 1377-1383.
12. Fass D, Harrison SC, Kim PS. Retrovirus envelope domain at 1.7 A resolution. Nat Struct Biol 1996; 3: 465-469.
13. Moore JP, McKeating JA, Weiss RA, Sattentau QJ. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 1990; 250: 1139-1142.
14. Hunter E, Swanstrom R. Retrovirus envelope glycoproteins. Curr Top Microbiol Immunol 1990; 157: 187-253.
15. Wyatt R et al. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J Virol 1995; 69: 5723-5733.
16. Sattentau QJ et al. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J Virol 1993; 67: 7383-7393.
17. Sattentau QJ, Zolla-Pazner S, Poignard P. Epitope exposure on functional, oligomeric HIV-1 gp41 molecules. Virology 1995; 206: 713-717.
18. Sattentau QJ, Moore JP. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J Exp Med 1991; 174: 407-415.
19. Maddon P et al. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and brain. Cell 1986; 47: 333-348.
20. + cells. Science 1993; 262: 2045-2050.
21. Hattori T et al. Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection. FEBS Lett 1989; 248: 48-52.
22. Dragic T, Picard L, Alizon M. Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins. J Virol 1995; 69: 1013-1018.
23. Alizon M, Dragic T. CD26 antigen and HIV fusion? Science 1994; 264: 1161-1162.
24. Patience C et al. CD26 antigen and HIV fusion? Science 1994; 264: 1159-1160.
25. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry factor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272: 872-877.
26. Deng H et al. Identification of a major coreceptor for primary isolates of HIV-1. Nature 1996; 381: 661-666.
27. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381: 667-673.
28. Rein A et al. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus env protein. J Virol 1994; 68: 1773-1781.
29. Wang H et al. Plasma membrane receptors for ecotropic murine retroviruses require a limiting accessory factor. J Virol 1991; 65: 6468-6477.
30. Siess DC, Kozak SL, Kabat D. Exceptional fusogenicity of Chinese hamster ovary cells with murine retroviruses suggests roles for cellular factor(s) and receptor clusters in the membrane fusion process. J Virol 1996; 70: 3432-3439.
31. Ragheb JA, Yu H, Hofmann T, Anderson WF. The amphotropic and ecotropic murine leukemia virus envelope TM subunits are equivalent mediators of direct membrane fusion: implications for the role of the ecotropic envelope and receptor in syncytium formation and viral entry. J Virol 1995; 69: 7205-7215.
32. Weiss RA, Tailor CS. Retrovirus receptors. Cell 1995; 82: 531-533.
33. Cosset F-L et al. Retroviral retargeting by envelopes expressing an N-terminal binding domain J Virol 1995; 69: 6314-6322.
34. Porter CD et al. Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptors. Hum Gene Ther 1996; 7: 913-919.
35. Miller DG, Miller AD. A family of retroviruses that utilise related phosphate transporters for cell entry. J Virol 1994; 68: 8270-8276.
36. Kavanaugh MP et al Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci USA 1994; 91: 7071-7075.
37. Kim J, Closs E, Albritton L, Cunningham J Transport of cationic amino acids by the mouse ecotropic receptor. Nature 1991; 352: 725-728.
38. Neda H, Wu C, Wu G. Chemical modification of an ecotropic murine leukemia virus results in redirection of its target cell specificity J Biol Chem 1991; 266: 14143-14149.
39. Goud B, Legrain P, Buttin G. Antibody-mediated binding of a murine ecotropic Moloney retroviral vector to human cells allows internalization but not the establishment of the proviral state. Virology 1988; 163: 251-254.
40. Roux P, Jeanteur P, Piechaczyk M. A versatile approach to the targeting of specific cell types by retroviruses. Proc Natl Acad Sci USA 1989; 86: 9079-9083.
41. Etienne-Julan M et al. The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker. J Gen Virol 1992; 73: 3251-3255.
42. Battini JL, Danos O, Heard JM. Receptor-binding domain of murine leukemia virus envelope glycoproteins J Virol 1995; 69: 713-719.
43. Bova CA, Olsen JC, Swanstrom R. The avian retrovirus env gene family: molecular analysis of host range and antigenic variants. J Virol 1988; 62: 75-83.
44. Valsesia-Wittmann S et al. Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors. J Virol 1994; 68: 4609-4619.
45. Linder M et al. Localization of the intrachain disulfide bonds of the envelope glycoprotein 71 from Friend murine leukemia virus. Eur J Biochem 1992; 203: 65-73.
46. Linder M, Wenzel V, Linder D, Stirm S. Structural elements in glycoprotein 70 from polytropic Friend mink cell focus-inducing virus and glycoprotein 71 from ecotropic Friend murine leukemia virus, as defined by disulfide-bonding pattern and limited proteolysis. J Virol 1994; 68: 5133-5141.
47. MacKrell AJ, Soong NW, Curtis CM, Anderson WF. Identification of a subdomain in the Moloney murine leukemia virus envelope protein involved in receptor binding. J Virol 1996; 70: 1768-1774.
48. Schnierle BS, Moritz D, Jeschke M, Groner B. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles. Gene Therapy 1996; 3: 334-342
49. Lobel LI, Goff SP. Construction of mutants of Moloney murine leukemia virus by suppressor-linker insertional mutagenesis: positions of viable insertion mutations. Proc Natl Acad Sci USA 1984; 81: 4149-4153.
50. Granowitz C, Colicelli J, Goff SP. Analysis of mutations in the envelope gene of Moloney murine leukemia virus: separation of infectivity from superinfection resistance. Virology 1991; 183: 545-554.
51. Berkowitz RD, Goff SP. Point mutations in Moloney murine leukemia virus envelope protein: effects on infectivity, virion association, and superinfection resistance. Virology 1993; 196: 748-757.
52. Gray KD, Roth MJ. Mutational analysis of the envelope gene of Moloney murine leukemia virus. J Virol 1993; 67: 3489-3496.
53. Kasahara N, Dozy AM, Kan YW. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 1994; 266: 1373-1376.
54. Han X, Kasahara N, Kan YW Ligand-directed retroviral targeting of human breast cancer cells. Proc Natl Acad Sci USA 1995; 92: 9747-9751.
55. Matano T, Odawara T, Iwamoto A, Yoshikura H. Targeted infection of a retiovirus bearing a CD4-Env chimera into human cells expressing human immunodeficiency virus type 1. J Gen Virol 1995; 76: 3165-3169.
56. Kabat D. Targeting retroviral vectors to specific cells. Science 1995; 269: 417.
57. Chu THT, Martinez I, Sheay WC, Dornburg R. Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins. Gene Therapy 1994; 1: 292-299.
58. Chu THT, Dornburg R. Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer. J Virol 1995; 69: 2659-2663.
59. Somia NV, Zoppé M, Verma IM. Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proc Natl Acaci Sci USA 1995; 92: 7570-7574.
60. Russell SJ, Hawkins RE, Winter G. Retroviral vectors displaying functional antibody fragments. Nucleic Acids Res 1993; 21: 1081-1085.
61. Marin M et al. Targeted infection of human cells via MHC class 1 molecules by MoMuLV-derived viruses displaying single-chain antibody fragment-envelope fusion proteins. J Virol 1996; 70: 2957-2962.
62. Valsesia-Wittmann S et al. Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU. J Virol 1996; 70: 2059-2064.
63. Ager S et al. Retroviral display of antibody fragments; interdomain spacing strongly influences vector infechvity. 1996 (submitted for publication).
64. Nilson BHK, Morling FJ, Cosset F-L, Russell SJ. Targeting of retroviral vectors through protease-substrate interactions. Gene Therapy 1996; 3: 280-286
65. Peng KW et al. A gene delivery system activatable by disease-associated matrix metalloproteinase. 1996 (submitted for publication).
66. Cosset F-L et al. High titer packaging systems producing recombinant retroviruses resistant to human serum. J Virol 1995; 69: 7430-7436.
67. Rigg RJ et al. A novel human amphotropic packaging cell line: high titer, complement resistance, and improved safety. Virology 1996; 218: 290-295.
68. Naldini L et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263-267.
69. Suomalainen M, Garoff H. Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus. J Virol 1994; 68: 4879-4889.
70. Buchholz CJ et al. Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion. J Virol 1996; 70: 3716-3723.